SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-072939
Filing Date
2014-12-09
Accepted
2014-12-09 14:08:59
Documents
11
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v395929_10q.htm 10-Q 251494
2 EXHIBIT 31.1 v395929_ex31-1.htm EX-31.1 10792
3 EXHIBIT 31.2 v395929_ex31-2.htm EX-31.2 10809
4 EXHIBIT 32.1 v395929_ex32-1.htm EX-32.1 4595
5 EXHIBIT 32.2 v395929_ex32-2.htm EX-32.2 4641
  Complete submission text file 0001144204-14-072939.txt   2505706

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lltp-20141031.xml EX-101.INS 206522
7 XBRL TAXONOMY EXTENSION SCHEMA lltp-20141031.xsd EX-101.SCH 23459
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lltp-20141031_cal.xml EX-101.CAL 33699
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lltp-20141031_def.xml EX-101.DEF 91303
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lltp-20141031_lab.xml EX-101.LAB 576144
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lltp-20141031_pre.xml EX-101.PRE 189692
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 141274761
SIC: 1000 Metal Mining